Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era-论文-万方医学网

首页> > Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era

Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era

导出原文传递

翻译打印收藏纠错

第一作者： Finocchiaro, Gherardo

作者： Finocchiaro, Gherardo ^[1] ; Magavern, Emma F. ^[2] ; Georgioupoulos, Georgios ^[3] ; Maurizi, Niccolo' ^[4] ; Sinagra, Gianfranco ^[5] ; Carr-White, Gerald ^[6] ; Pantazis, Antonis ; Olivotto, Iacopo

作者单位： Guy's & St Thomas' NHS Foundation Trust,Guys & St Thomas Hosp ^[1] William Harvey Res Inst,London Sch Med & Dent ^[2] University of London,Kings Coll London ^[3] Cardiomyopathy Unit,Careggi Univ Hosp ^[4] Cardiovasc Dept,Univ Trieste ^[5] Royal Brompton Hospital,Royal Brompton Hosp ^[6]

关键词 Cardiomyopathy Sudden death Risk stratification IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR RIGHT-VENTRICULAR CARDIOMYOPATHY NORTH-AMERICAN MULTIDISCIPLINARY LATE GADOLINIUM ENHANCEMENT HYPERTROPHIC CARDIOMYOPATHY DILATED CARDIOMYOPATHY COST-EFFECTIVENESS PRIMARY PREVENTION EUROPEAN-SOCIETY CLINICAL-COURSE

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era

相似文献

同项目论文

相关期刊

检索历史 清除

Sudden cardiac death in cardiomyopathies: acting upon "acceptable" risk in the personalized medicine era

相似文献

同项目论文

相关期刊

检索历史清除